AGN — Argenica Therapeutics Share News
0.000.00%
Last trade - 00:00- AU$14.13m
- AU$9.09m
- AU$0.51m
Brief: Argenica Therapeutics Says Dianne Angus To Step Down As Non-Executive Chair
Australia's Argenica Therapeutics jumps on meeting FDA condition
Brief: Argenica Therapeutics Seeks Trading Halt
Brief: Argenica Therapeutics Gets Non-Dilutive Funding Up To A Total Of A$1.5M
Australia's Argenica Therapeutics rises on funding from federal government
Brief: Argenica Therapeutics Says US FDA Placed Clinical Hold On Investigational New Drug Application
Australia's Argenica Therapeutics tumbles as FDA halts stroke drug application
Refile: BUZZ-Argenica Therapeutics rises on approval to continue trials from safety board
Australia's Argenica Therapeutics jumps on positive test results for FDA application
Brief: Argenica Therapeutics Successfully Completes A$12.0M Placement
Australia's Argenica Therapeutics falls on discounted placement
Brief: Argenica Therapeutics Seeks Trading Halt
Brief: Argenica Therapeutics Says FDA Grants Argenica Rare Pediatric Disease Designation For Arg-007
Australia's Argenica Therapeutics jumps on FDA designation for neuroprotective drug
Brief: Argenica Therapeutics Says Appointment Of Dianne Angus As Non- Executive Chair
Australia's Argenica Therapeutics surges after drug gets FDA orphan status
Brief: Argenica Therapeutics Says Food And Drug Administration Has Granted Orphan Drug Designation Status To ARG-007
Brief: Argenica Therapeutics Receives Positive Feedback On Arg-007
Brief: Argenica Therapeutics Says Completes A$4.0M Placement